| Terminated | A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Healthy Study Participants, Impaired Hepatic Function | Phase 1 | 2019-10-28 |
| Terminated | A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants Healthy Study Participants | Phase 1 | 2019-10-23 |
| Completed | A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants Healthy Japanese Participants | Phase 1 | 2019-09-30 |
| Terminated | A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Healthy Participants | Phase 1 | 2019-07-17 |
| Completed | A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly St Elderly Study Participants, Adult Study Participants | Phase 1 | 2019-07-09 |
| Completed | A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Pa Parkinson's Disease | Phase 1 | 2019-05-06 |
| Completed | A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizum Healthy Volunteers | Phase 1 | 2019-04-02 |
| Completed | A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammato Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Phase 2 | 2019-03-26 |
| Completed | A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcu Healthy-volunteers | Phase 1 | 2019-03-18 |
| Completed | A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Briv Partial Seizures With or Without Secondary Generalization, Epilepsy | Phase 3 | 2019-01-04 |
| Completed | A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by Healthy Volunteers | Phase 1 | 2018-10-15 |
| Completed | A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazep Epilepsy | Phase 1 | 2018-09-18 |
| Completed | A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanes Healthy Japanese Volunteers | Phase 1 | 2018-07-25 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= Epilepsy | Phase 2 | 2018-06-01 |
| Completed | Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil Pharmacokinetics | Phase 1 | 2018-03-27 |
| Completed | A Study to Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UC Healthy Male Volunteers | Phase 1 | 2018-02-16 |
| Completed | Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults Drug-resistant Epilepsy, Focal-Onset Seizures | Phase 2 | 2018-02-12 |
| Terminated | A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS) Infantile Spasms (IS) | Phase 2 | 2017-12-04 |
| Completed | Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution Moderate and Severe Active Rheumatoid Arthritis, Active Psoriatic Arthritis, Active Ankylosing Spondylitis | Phase 3 | 2017-11-03 |
| Completed | A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Ta Healthy Male Chinese Volunteers | Phase 1 | 2017-06-08 |
| Completed | Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Myasthenia Gravis | Phase 2 | 2017-05-15 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Cauca Healthy Japanese and Caucasian Subjects | Phase 1 | 2017-05-05 |
| Completed | Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´ Parkinson´s Disease | Phase 4 | 2017-03-16 |
| Completed | A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Healthy Male Volunteers | Phase 1 | 2017-02-27 |
| Completed | A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chr Moderate to Severe Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis | Phase 2 / Phase 3 | 2017-02-21 |
| Completed | A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Ep Epilepsy | Phase 2 | 2017-02-06 |
| Completed | A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subject Healthy Volunteers | Phase 1 | 2016-11-01 |
| Completed | A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subject Psoriatic Arthritis | Phase 2 | 2016-10-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosi Ankylosing Spondylitis | Phase 2 | 2016-10-01 |
| Completed | A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2016-08-01 |
| Completed | Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoria Chronic Plaque Psoriasis | Phase 2 | 2016-08-01 |
| Completed | A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2016-07-11 |
| Completed | A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus Systemic Lupus Erythematosus (SLE) | Phase 2 | 2016-06-02 |
| Completed | Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset S Epilepsy With POS With or Without Secondary Generalization | — | 2016-02-01 |
| Completed | Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers Healthy Volunteers | Phase 1 | 2016-01-01 |
| Completed | A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study Epilepsy | Phase 3 | 2016-01-01 |
| Completed | A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy Highly Drug-resistant Focal Epilepsy | Phase 2 | 2015-07-01 |
| Completed | Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Pl Psoriasis, Plaque Psoriasis | Phase 3 | 2015-02-11 |
| Completed | A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Li Axial Spondyloarthritis | — | 2015-01-12 |
| Completed | An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis Psoriasis, Plaque Psoriasis | Phase 3 | 2014-12-16 |
| Completed | A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Pl Psoriasis, Plaque Psoriasis | Phase 3 | 2014-12-15 |
| Completed | Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Bloo Systemic Lupus Erythematosus | Phase 1 | 2014-11-01 |
| Completed | Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson Idiopathic Parkinson's Disease | — | 2014-09-01 |
| Terminated | A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters Epilepsy | Phase 3 | 2014-05-01 |
| Completed | Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in th Epilepsy | Phase 3 | 2013-11-01 |
| Terminated | Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters Epilepsy | Phase 3 | 2012-07-01 |
| Terminated | Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters Epilepsy | Phase 3 | 2011-06-01 |
| No Longer Available | Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures Epilepsies, Partial | — | — |